glp-1 food industry news today Weight loss drug patients spend less on restaurants, takeout: survey Ozempic Could Crush the Junk

1 Noom notes that there are three essential hurdles that are hindering progress along this front: The cost of medication The sides effects of medication An absence of sustainable behavior change In fact, among patients who begin utilizing GLP-1s, over 50% of them stop as a result of cost, while 36% stop because of side effects

(You can search the NIHR 'Be Part of Research' website, but always discuss eligibility with your clinician) What are the established treatment options that might better address my symptoms

Heart disease is driven by a range of issues, including insulin resistance, chronic inflammation, and blood vessel dysfunction

Concomitant medications may also contribute to musculoskeletal symptoms

Sartor GC, Aston-Jones GS (2012)